BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 4007783)

  • 1. Hepatotoxicity from antithyroid drugs.
    Vitug AC; Goldman JM
    Horm Res; 1985; 21(4):229-34. PubMed ID: 4007783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity.
    Akmal A; Kung J
    Expert Opin Drug Saf; 2014 Oct; 13(10):1397-406. PubMed ID: 25156887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic treatment of hyperthyroidism during pregnancy.
    Cassina M; Donà M; Di Gianantonio E; Clementi M
    Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):612-9. PubMed ID: 22511519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose.
    Cooper DS; Goldminz D; Levin AA; Ladenson PW; Daniels GH; Molitch ME; Ridgway EC
    Ann Intern Med; 1983 Jan; 98(1):26-9. PubMed ID: 6687345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-B*38:02:01 predicts carbimazole/methimazole-induced agranulocytosis.
    Cheung CL; Sing CW; Tang CS; Cheng VK; Pirmohamed M; Choi CH; Hung CS; Lau EY; Lee KF; Mak MW; Leung JY; Wong TW; Ho AY; Chan KW; Hung V; Tam V; Siu SC; Pang HK; Wat WZ; Lee HH; Chung CT; Hue RS; Sham PC; Cheung BM; Wong IC; Tan KC; Kung A
    Clin Pharmacol Ther; 2016 May; 99(5):555-61. PubMed ID: 26599303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children.
    Rivkees SA; Szarfman A
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3260-7. PubMed ID: 20427502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent agranulocytosis induced by two different antithyroid agents.
    Chen B; Lang R; Jutrin Y; Ravid M
    Med J Aust; 1983 Jul; 2(1):38-9. PubMed ID: 6865827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teratogen update: antithyroid drugs-methimazole, carbimazole, and propylthiouracil.
    Diav-Citrin O; Ornoy A
    Teratology; 2002 Jan; 65(1):38-44. PubMed ID: 11835230
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrent agranulocytosis following carbimazole and propylthiouracil therapy.
    Ostlere S; Apthorp GH
    Br J Clin Pract; 1988 Nov; 42(11):474-5. PubMed ID: 3256337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agranulocytosis and antithyroid drugs.
    Rosove MH
    West J Med; 1977 May; 126(5):339-43. PubMed ID: 867981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithyroid drug-induced aplastic anemia.
    Thomas D; Moisidis A; Tsiakalos A; Alexandraki K; Syriou V; Kaltsas G
    Thyroid; 2008 Oct; 18(10):1043-8. PubMed ID: 18816182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propylthiouracil versus methimazole during pregnancy: an evolving tale of difficult choices.
    Rivkees SA
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4332-5. PubMed ID: 24194618
    [No Abstract]   [Full Text] [Related]  

  • 13. Methimazole-induced hepatotoxicity.
    Woeber KA
    Endocr Pract; 2002; 8(3):222-4. PubMed ID: 12467281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute cholestatic hepatitis along with agranulocytosis: a rare side effect of carbimazole.
    Jain K; Chakrapani M; Smitha K
    Ann Afr Med; 2010; 9(2):102-4. PubMed ID: 20587933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin receptor antibodies and a genetic hint in antithyroid drug-induced adverse drug reactions.
    Chang LC; Chang CC; Chen PL; Wang SH; Chen YH; Tsai YH; Shih SR; Chiu WY; Fann CS; Yang WS; Chang TC
    Expert Opin Drug Saf; 2018 Aug; 17(8):775-784. PubMed ID: 30067105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
    Wall JR; Fang SL; Kuroki T; Ingbar SH; Braverman LE
    J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Antithyroid Drug-Induced Agranulocytosis in Patients with Hyperthyroidism: A Retrospective Analysis of 114 Cases in a Single Institution in China Involving 9690 Patients Referred for Radioiodine Treatment Over 15 Years.
    Yang J; Zhu YJ; Zhong JJ; Zhang J; Weng WW; Liu ZF; Xu Q; Dong MJ
    Thyroid; 2016 May; 26(5):627-33. PubMed ID: 26867063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The occurrence of agranulocytosis due to antithyroid drugs in a cohort of patients with Graves disease treated with radioactive iodine 131I during 14 years].
    Cepková J; Gabalec F; Svilias I; Horáček J
    Vnitr Lek; 2014 Oct; 60(10):832-6. PubMed ID: 25382005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK.
    Pearce SH
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):589-94. PubMed ID: 15521961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study.
    Wang MT; Lee WJ; Huang TY; Chu CL; Hsieh CH
    Br J Clin Pharmacol; 2014 Sep; 78(3):619-29. PubMed ID: 25279406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.